RT Journal Article
SR Electronic
T1 COVID-19 pandemic control: balancing detection policy and lockdown intervention under ICU sustainability
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.13.20100842
DO 10.1101/2020.05.13.20100842
A1 Arthur Charpentier
A1 Romuald Elie
A1 Mathieu Laurière
A1 Viet Chi Tran
YR 2020
UL http://medrxiv.org/content/early/2020/05/16/2020.05.13.20100842.abstract
AB We consider here an extended SIR model, including several features of the recent COVID-19 outbreak: in particular the infected and recovered individuals can either be detected (+) or undetected (−) and we also integrate an intensive care unit capacity. Our model enables a tractable quantitative analysis of the optimal policy for the control of the epidemic dynamics using both lockdown and detection intervention levers. With parametric specification based on literature on COVID-19, we investigate sensitivity of various quantities on optimal strategies, taking into account the subtle tradeoff between the sanitary and the economic cost of the pandemic, together with the limited capacity level of ICU. We identify the optimal lockdown policy as an intervention structured in 4 successive phases: First a quick and strong lockdown intervention to stop the exponential growth of the contagion; second a short transition phase to reduce the prevalence of the virus; third a long period with full ICU capacity and stable virus prevalence; finally a return to normal social interactions with disappearance of the virus. We also provide optimal intervention measures with increasing ICU capacity, as well as optimization over the effort on detection of infectious and immune individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementV.C.T. has been supported by ANR Cadence (ANR-16-CE32-0007) and by the Chair “Modélisation Mathématique et Biodiversité” of Veolia Environnement-Ecole Polytechnique-Museum National d’Histoire Naturelle-Fondation X.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe have only used data from other research reports or publications or found on the website of the WHO.